Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy (Adv. Sci. 12/2025)
Huiwen Liu, Bo Zhang, Hongrui Chen, Honglan Wang, Xifeng Qin, Chunyan Sun, Zhiqing Pang, Yu Hu
{"title":"Targeted Delivery of c(RGDfk)-Modified Liposomes to Bone Marrow Through In Vivo Hitchhiking Neutrophils for Multiple Myeloma Therapy (Adv. Sci. 12/2025)","authors":"Huiwen Liu, Bo Zhang, Hongrui Chen, Honglan Wang, Xifeng Qin, Chunyan Sun, Zhiqing Pang, Yu Hu","doi":"10.1002/advs.202570079","DOIUrl":null,"url":null,"abstract":"<p><b>Targeted Drug Delivery to the Bone Marrow</b></p><p>In article number 2409895, Liu Huiwen, Zhiqing Pang, Yu Hu, and co-workers introduce an innovative bone marrow-targeting strategy that utilizes c(RGDfk)-modified liposomes as therapeutic carriers. These liposomes (the cargo) exploit aging neutrophils (the purple cells), known for their intrinsic ability to home to the bone marrow, as natural transport vehicles. This approach outperformed conventional drug delivery systems by enhancing precision and minimizing off-target effects.\n\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":117,"journal":{"name":"Advanced Science","volume":"12 12","pages":""},"PeriodicalIF":14.3000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/advs.202570079","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Science","FirstCategoryId":"88","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/advs.202570079","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Targeted Drug Delivery to the Bone Marrow
In article number 2409895, Liu Huiwen, Zhiqing Pang, Yu Hu, and co-workers introduce an innovative bone marrow-targeting strategy that utilizes c(RGDfk)-modified liposomes as therapeutic carriers. These liposomes (the cargo) exploit aging neutrophils (the purple cells), known for their intrinsic ability to home to the bone marrow, as natural transport vehicles. This approach outperformed conventional drug delivery systems by enhancing precision and minimizing off-target effects.
期刊介绍:
Advanced Science is a prestigious open access journal that focuses on interdisciplinary research in materials science, physics, chemistry, medical and life sciences, and engineering. The journal aims to promote cutting-edge research by employing a rigorous and impartial review process. It is committed to presenting research articles with the highest quality production standards, ensuring maximum accessibility of top scientific findings. With its vibrant and innovative publication platform, Advanced Science seeks to revolutionize the dissemination and organization of scientific knowledge.